I share evidence-based cancer news, research breakthroughs and survivor stories — no hype, no miracle cures.
This feed is for patients, families, clinicians and anyone who believes progress matters.
Follow for facts, hope & real science!
Curated by @Chris_Geiger#TCSC
Researchers at UC Irvine have uncovered a mechanism that could help cancer treatments trigger a stronger immune response against tumours. A promising step in the search for more effective therapies.
eurekalert.org/news-releases…#CancerResearch#Immunotherapy#TCSC
Scientists have identified a hidden immune-system “brake” that may help cancers avoid destruction. The discovery could lead to treatments that make immunotherapy work better for more patients.
sciencedaily.com/releases/20…#Immunotherapy#CancerResearch#TCSC
Are we getting closer to beating cancer? New advances in early detection, personalised treatments and immunotherapy are helping more people live longer and better after diagnosis.
theguardian.com/world/2026/j…#CancerResearch#Oncology#TCSC
McGill researchers found that blocking just two proteins transforms the immune system’s natural killer cells into far more powerful cancer fighters; effective against leukemia, glioblastoma, kidney & triple-negative breast cancer. #TCSC#Cancer#Oncologysciencedaily.com/releases/20…
Cats may be cancer research’s next big frontier. A landmark study in Science genetically mapped tumours from nearly 500 cats and found striking overlaps with human breast cancer, leukemia and glioblastoma. #TCSC#CancerResearch#Oncologysciencedaily.com/releases/20…
UW spinoff Archeus Technologies has just dosed the first patient with ARC-706; a new targeted radiopharmaceutical designed to boost immunotherapy in metastatic cancers. Phase 1 is underway. Nuclear medicine is moving fast. #TCSC#CancerResearch#Oncologybiospace.com/press-releases/…
A common asthma pill! Singulair (montelukast); may help restore immunotherapy response in cancers that have stopped responding. Northwestern researchers discovered tumors exploit a molecule called CysLTR1 to evade treatment. #TCSC#CancerResearch#Oncologymedicalxpress.com/news/2026-…